
Congressional disclosures
Gary J. Palmer
Republican · House · Alabama · District 6 · serving since 2015 · last filed 8 years ago
Recent disclosures
20 of 260 on record · traded Oct 5, 2018Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Asset | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| CELGENE CORPORATIONJointHealthcare | Stock | Sale · 2 lines | $1,001 - $15,000 | n/aPrice history ends Nov 20, 2019 | Oct 5, 2018 | Nov 7, 2018 | 33d |
| COFSpouseFinancial Services | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| AAPLJointTechnology | Stock | Sale · 3 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| TCommunication Services | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| CSCOTechnology | Stock | Sale · 3 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| SYYConsumer Defensive | Stock | Sale · 3 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| MASpouseFinancial Services | Stock | Sale · 2 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| VMWTechnology | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Nov 24, 2023 | Oct 5, 2018 | Nov 7, 2018 | 33d |
| ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARESHealthcare | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| MPCSpouseEnergy | Stock | Sale · 3 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| ESRXOther | Stock | Sale · 3 lines | $1,001 - $15,000 | n/aPrice history ends Dec 20, 2018 | Oct 5, 2018 | Nov 7, 2018 | 33d |
| AMGNSpouseHealthcare | Stock | Sale · 3 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| CENTURYLINK, INC.SpouseCommunication Services | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Sep 17, 2020 | Oct 5, 2018 | Nov 7, 2018 | 33d |
| MTDHealthcare | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| NTRSSpouseFinancial Services | Stock | Sale · 2 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| BASpouseIndustrials | Stock | Sale · 2 lines | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| CMCSAJointCommunication Services | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| WBAHealthcare | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Aug 27, 2025 | Oct 5, 2018 | Nov 7, 2018 | 33d |
| LYBSpouseBasic Materials | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
| BBYSpouseConsumer Cyclical | Stock | Sale | $1,001 - $15,000 | n/a | Oct 5, 2018 | Nov 7, 2018 | 33d |
No disclosures of that kind among the 20 rows shown.
Showing the 20 most recent disclosures. Lines for the same asset, day, band and action are shown once and marked with the number of lines. All of Gary J. Palmer's trades in the browser, every line of every report.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
Estimated portfolio
9 holdings · $1,000,001 - $5,000,000 in total · estimate, as of Oct 26, 2026| Holding | Estimated value | Share of portfolio |
|---|---|---|
| OACP | $250,001 - $500,000 | 26.3% |
| OALC | $250,001 - $500,000 | 21.8% |
| OAIM | $100,001 - $250,000 | 13.0% |
| ELCV | $100,001 - $250,000 | 9.6% |
| OASC | $100,001 - $250,000 | 9.5% |
| VGIT | $50,001 - $100,000 | 7.9% |
| OAEM | $50,001 - $100,000 | 5.0% |
| OWNS | $15,001 - $50,000 | 3.9% |
| EQH | $15,001 - $50,000 | 3.0% |
All 9 estimated holdings. Every figure is an estimate built from the ranges on the member's financial disclosure reports, marked by the price movement of each stock since the filing; the share is of the whole estimated portfolio, small positions included. These are the stock and fund positions the model prices; the net worth estimate above also counts other disclosed assets and subtracts liabilities.
Year by year
buy volume against sale and exchange volume · range midpoints- Bought
- Sold or exchanged
- 2018Bought $1.0MSold or exchanged $512K
- 2017Bought $536KSold or exchanged $32K
- Bought
- Sold or exchanged
Disclosed volume per year the member traded, 2017 to 2018. A filing gives a range, not an amount, so each bar sums the midpoints of the ranges disclosed that year: a $1,001 to $15,000 line counts as $8,000. The sale side also counts exchanges, including shares received in a spin-off or merger.
Where the disclosed portfolio sits
share of the estimated portfolio- Funds & ETFs97.0%
- Financial Services3.0%
Questions
How many stock trades has Gary J. Palmer disclosed?
Gary J. Palmer has disclosed 260 transactions under the STOCK Act. This page lists the 20 most recent, covering Oct 5, 2018.
How long does Gary J. Palmer take to report a trade?
For trades made from Apr 2017 to Oct 2018, the median gap between a trade and its disclosure is 79 days. The STOCK Act allows up to 45.
Which accounts do Gary J. Palmer's disclosures name?
Of the 20 disclosures shown, 9 name a spouse's account and 3 a joint account. 8 do not name an account. The account is whatever the filer wrote on the disclosure; a spouse's or a joint account is disclosed under the member's name, as the STOCK Act requires.
Where does the estimated net worth on this page come from?
A model's estimate, not a figure the member filed. Reports give every asset and debt as a range, so the model takes a value inside each range, subtracts debts and prices the stocks it tracks at the latest close we hold. We round it because the top range has no upper limit. It covers only what the reports carry and is not a measure of anyone's wealth. The methodology page sets out how it is built and what it leaves out.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
A disclosure is a record of a transaction, not evidence of anything else, and nothing here is investment advice. Sourcing and the limits of this data are on the methodology page. How these reports work is explained in our guide to STOCK Act reports.
Data as of Oct 27, 2026.
